Operating Lease, Right-of-Use Asset of Immunome Inc. from 01 Jan 2022 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Immunome Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2022 to 30 Sep 2025.
  • Immunome Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $3,125,000, a 31% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Immunome Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $3,125,000 +$737,000 +31% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $3,269,000 +$746,000 +30% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $4,163,000 +$2,705,000 +186% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $4,278,000 +$2,714,000 +174% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $2,388,000 +$2,043,000 +592% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 $2,523,000 +$2,349,000 +1350% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 $1,458,000 +$1,228,000 +534% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $1,564,000 +$1,280,000 +451% 31 Dec 2023 10-K 19 Mar 2025 2024 FY
Q3 2023 $345,000 +$174,000 +102% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $174,000 -$8,000 -4.4% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $230,000 +$40,000 +21% 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 $284,000 -$216,000 -43% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 $171,000 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $182,000 30 Jun 2022 10-Q 05 Aug 2022 2022 Q2
Q1 2022 $190,000 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $500,000 01 Jan 2022 10-K 16 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.